Page 13 - Pharma Companies

Dr Reddy's Laboratories inks licensing pact with US' Slayback Pharma

Dr Reddy's Laboratories on Saturday said it has entered into a pact with US-based Slayback Pharma to acquire rights of a medication to relieve redness of the eyes

Syngene International signs 10-year agreement with US-based firm Zoetis

Librela or bedinvetmab has already been launched in Europe and the UK, and has won 'Best new companion animal product' by IHS Markit Connect in 2021

Glenmark nasal spray cuts down viral load of Covid by 94% in 24 hrs

Glenmark had conducted the study on 306 vaccinated and unvaccinated adults with symptomatic mild Covid-19 disease across 20 clinical trial sites in India

Results preview: Pharma margins likely to remain under pressure in Q1

Hospitals back to normalcy; tough road ahead for diagnostics

Dolo-650 manufacturer faces raids by I-T dept in tax evasion case

A team of more than 20 officers associated with the I-T dept conducted the raids on the pharma company's Race Course Road office

Research-linked incentive scheme in works for pharmaceutical industry

15% turnover investment in research could make companies eligible for the scheme

DCGI approves indigenous mRNA Covid jab for emergency use in adults: Report

It is for the first time ever that Covid-19 vaccine remains stable during storage even at 2-8 degrees Celsius

Glenmark acquires Wockhardt's key OTC brands in US for undisclosed sum

Deal includes approved ANDAs for famotidine tablets, used in treatment and prevention of ulcers stomach and intestinal ulcers

Glenmark Pharmaceuticals acquires certain OTC drugs from Wockhardt in US

Glenmark said its current portfolio consists of 175 products authorised for distribution in the US market and 48 ANDAs pending approval with the USFDA

CBI arrests Jt Drug Controller, Biocon Biologics execs over fishy approvals

All five apprehended will be presented in court on Tuesday afternoon, agency to seek police custody

Cipla to acquire 21% stake in diagnostic company Achira Labs for Rs 25 cr

The company has signed definitive agreements with Achira Labs for the purpose, Cipla said in a regulatory filing

Sun Pharma plans to expand field force in India by 10% this fiscal

The Mumbai-based drug major currently employs around 11,000 Medical Representatives and related staff in India

Growth worries to keep Divi's Labs under pressure in the near term

Valuations, too, are on the higher side, say brokerages

Madurai to Agra, smaller towns witness strong growth in sales of medicines

In terms of launches, around 68% have been in acute therapy in last 12 months, data shows

Lupin logs net loss of Rs 512 cr in Q4 on rising costs, impairment expense

Quarter was challenging due to 'headwinds in the US on account of price erosion', says company.

PE firm Multiples picks up 9.3% stake in BDR Pharma for Rs 685 cr

Multiples is the first private equity (PE) investor in BDR Pharma

GlaxoSmithKline Pharma reports consolidated net loss of Rs 55 crore

Revenue from operations rose to Rs 810 crore for the fourth quarter, compared with Rs 744 crore in the year-ago period, the pharmaceutical major said in a regulatory filing

Moderna CFO exits day after taking charge as former employer launches probe

Jorge Gomez previously worked for dental products maker Dentsply Sirona, which last month fired its CEO.

Sanofi India: Strong balance sheet, high cash reserves positives for stock

Products in the price control list and growth of the non-power brand portfolio will be key monitorables

Cost pressure likely to weigh on pharma companies' margins in Q4

Among Indian firms, Edelweiss feels that Cipla (respiratory) and Sun Pharma (specialty) are better placed to tide the price erosion